SCHEMBL6175494

SCHEMBL6175494

CCN1CCN(C(=O)c2cc(C(C)C3(C(C)c4ccnc(C(=O)N5CCN(CC)CC5)c4)NC(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C3=O)ccn2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.35
TACR1 P25103 1/20 0.34
CCNT1 O60563 2/20 0.33
CDK9 P50750 2/20 0.33
SCN9A Q15858 2/20 0.33
SCN7A Q01118 1/20 0.33
KCNH2 Q12809 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
HPGD P15428 1/20 0.32
KMT2A Q03164 1/20 0.32
AR P10275 1/20 0.32
TRPV3 Q8NET8 2/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HRH4 Q9H3N8 1/20 0.31
SLC6A9 P48067 1/20 0.30
PARP1 P09874 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175019 0.90 DPP4 (0.37) IGF1RTACR1SCN9ASCN7AKCNH2
SCHEMBL6175941 0.89 PTGS2 (0.39) IGF1RTACR1SCN9ASCN7AKCNH2
SCHEMBL6173425 0.88 LMNA (0.38) IGF1RL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL6172914 0.85 IGF1R (0.38) IGF1RMEN1KMT2AARTRPV3
SCHEMBL6173852 0.84 IGF1R (0.37) IGF1RKMT2AARTRPV3HRH4
SCHEMBL6203204 0.81 IGF1R (0.40) IGF1RMEN1KMT2AARTRPV3
SCHEMBL6175022 0.80 IGF1R (0.40) IGF1RMEN1KMT2AARTRPV3
SCHEMBL6172497 0.79 IGF1R (0.37) IGF1RALDH1A1KMT2AARTRPV3
SCHEMBL6201343 0.79 PTGS2 (0.40) IGF1RMEN1KMT2AARTRPV3
SCHEMBL6177630 0.79 IGF1R (0.39) IGF1RMEN1KMT2AARTRPV3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed